Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these thera...
Συγγραφή απο Οργανισμό/Αρχή: | SpringerLink (Online service) |
---|---|
Άλλοι συγγραφείς: | Ferreri, Andrés J. M. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt) |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
Έκδοση: | 1st ed. 2018. |
Σειρά: | Resistance to Targeted Anti-Cancer Therapeutics,
17 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Παρόμοια τεκμήρια
-
Current Applications for Overcoming Resistance to Targeted Therapies
Έκδοση: (2019) -
Cancer Stem Cell Resistance to Targeted Therapy
Έκδοση: (2019) -
Innovations for Next-Generation Antibody-Drug Conjugates
Έκδοση: (2018) -
Targeted Therapies for Lung Cancer
Έκδοση: (2019) -
Estrogen Receptor and Breast Cancer Celebrating the 60th Anniversary of the Discovery of ER /
Έκδοση: (2019)